300158.SZ
振东制药
SZSE · Healthcare · C 制造业 · CN
CNY 5.10
−2.30%Margins
Gross margin
51.2%
EBITDA margin
-5.2%
EBIT margin
-10.2%
Net margin
-11.3%
FCF margin
-22.7%
-9.1%
Return on equity
-6.8%
Return on assets
-7.6%
Return on invested capital
0.59x
Asset turnover
-CNY 434.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026